Carisma Therapeutics Inc. (NASDAQ: CARM)
$1.31
+0.0500 ( +3.97% ) 419.1K
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
Market Data
Open
$1.31
Previous close
$1.26
Volume
419.1K
Market cap
$54.01M
Day range
$1.25 - $1.38
52 week range
$0.99 - $9.77
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 18, 2024 |
8-k | 8K-related | 13 | Jun 14, 2024 |
8-k | 8K-related | 13 | Jun 14, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
10-q | Quarterly Reports | 68 | May 09, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |